EBV LMP2A逆转录病毒表达载体的构建及产毒细胞系的建立(4)

2025-06-14

上述研究表明LMP2A的抗凋亡活性，与其在抗肿瘤中应用的潜在价值存在一定冲突。本研究以逆转录病毒为载体构建携带LMP2A的重组质粒pMSCVpuro2A，旨在采用该重组体转染包装细胞，组装成携带并能转录表达LMP2A的重组逆转录病毒，然后再使用该病毒感染靶细胞，从而深入探讨LMP2A分子的生物活性以及LMP2A用于EBV相关肿瘤生物治疗的安全性。
【参考文献】
[1]TAKANO Y, KATO Y, SAEQUSA M, et al. The role of the EpsteinBarr virus in the oncogenesis of EBV (+) gastric carcinomas[J]. Virchows Arch, 1999,434:1722.

[2]SUBKLEWE M, CHAHROUDI A, SCHMAIJOHN A, et al. Induction of EpsteinBarr virus specific cytotoxic Tlymphocyte responses using dendritic cells pulsed with EBNA3A peptides or uvinactivated, recombinant EBNA3A vaccinia virus[J]. Blood, 1999,94:13721381.

[3]RANIERI E,HERR W, GAMBOTTO A, et al. Dendritic cells transduced with an adenovirus vector encoding EpsteinBarr virus latent membrane protein 2B; a new modality for vaccination[J]. J Virol, 1999,73:1041610425.

[4]LEE S P, TIERNEY R J, THOMAS W A, et al. Conserved CTL epitopes within EBVlatent membrane protein 2: a potential target for CTLbased tumor therapy[J]. J Immunol, 1997,158:33253334.

[5]LEVISKAYA J M, CORAM V, LEVITSY S, et al. Inhibition of antigen processing by the internal repeat region of the EpsteinBarr virus nuclear antigen[J]. Nature, 1995,375:685688.

[6]殷凡，王笑峰，罗兵. 特异性沉默EBV潜伏期基因LMP1 pSUPER retro RNAi系统的构建[J]. 齐鲁医学杂志， 2006，21（3）：197200.

[7]CHEN S Y, LU J, SHIH Y C, et al. EpsteinBarr virus latent membrane protein 2A regulates cJun protein through extracellular signalregulated kinase[J]. J Virol, 2002,76:95569561.

[8]ENGELS N, MERCHANT M, PAPPU R, et al. EpsteinBarr virus latent membrane protein 2A (LMP2A) employs the SLP65 signaling module[J]. J Exp Med, 2001,194:255264.

[9]PORTIS T, LONGNECKER R. EpsteinBarr virus (EBV) LMP2A alters normal transcriptional regulation following Bcell receptor activation[J]. Virology, 2004,318:524533.

共4页:

EBV LMP2A逆转录病毒表达载体的构建及产毒细胞系的建立(4).doc 将本文的Word文档下载到电脑下载失败或者文档不完整，请联系客服人员解决！

下载这篇word文档